The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice

Genes, Brain and Behavior - Tập 6 Số 8 - Trang 776-783 - 2007
J. Chen1, Lorenzo Rinaldo1, Sabina Lim1, Hannah Young2, Robert O. Messing3, Doo‐Sup Choi1
1Mayo Clinic Rochester-MN
2University of California at San Francisco
3Waggoner Center for Alcohol & Addiction Research

Tóm tắt

Activation of adenosine receptors in the brain reduces anxiety‐like behavior in animals and humans. Because nucleoside transporters regulate adenosine levels, we used mice lacking the type 1 equilibrative nucleoside transporter (ENT1) to investigate whether ENT1 contributes to anxiety‐like behavior. The ENT1 null mice spent more time in the center of an open field compared with wild‐type littermates. In the elevated plus maze, ENT1 null mice entered more frequently into and spent more time exploring the open arms. The ENT1 null mice also spent more time exploring the light side of a light–dark box compared with wild‐type mice. Microinjection of an ENT1‐specific antagonist, nitrobenzylthioinosine (nitrobenzylmercaptopurine riboside), into the amygdala of C57BL/6J mice reduced anxiety‐like behavior in the open field and elevated plus maze. These findings show that amygdala ENT1 modulates anxiety‐like behavior. The ENT1 may be a drug target for the treatment of anxiety disorders.

Từ khóa


Tài liệu tham khảo

10.1038/sj.npp.1300232

10.1016/S0169-328X(99)00164-3

10.1046/j.1471-4159.1999.0730867.x

10.1016/0091-3057(89)90230-X

10.1007/s00424-003-1103-2

10.1074/jbc.M414337200

10.1016/j.tins.2006.03.002

10.1111/j.1748-1716.1991.tb09133.x

10.1038/nn1288

Concas A., 1994, 2‐Chloro‐N6‐cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats, Alcohol Alcohol, 29, 261

10.1126/science.284.5420.1670

10.1074/jbc.273.9.5288

Crawley J.N, 2000, What’s Wrong with my Mouse? Emotional Behaviors: Animal Models of Psychiatric Diseases

10.1016/0091-3057(80)90067-2

10.1016/S0006-8993(96)01263-2

10.1016/S0361-9230(01)00552-4

10.1146/annurev.neuro.24.1.31

Franklin K.B.J., 2001, The Mouse Brain

Fredholm B.B., 1999, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol Rev, 51, 83

10.1046/j.1471-4159.2003.01957.x

10.1146/annurev.neuro.27.070203.144212

10.1007/BF02244256

10.1038/nm0197-89

10.1042/bj3280739

10.1038/sj.npp.1300311

10.1080/09687680118799

10.1111/j.1476-5381.1995.tb16421.x

10.1016/S0028-3908(00)00207-0

10.1016/S0741-8329(99)00033-6

10.1001/archpsyc.1994.03950010008002

10.1016/S0272-7358(99)00027-6

10.1038/41771

10.1007/BF00177912

10.1016/S0021-9258(19)39923-5

10.1016/0165-0270(85)90031-7

10.1038/sj.npp.1301001

10.1111/j.1360-0443.1997.tb02848.x

10.1523/JNEUROSCI.16-05-01877.1996

10.1074/jbc.272.45.28423

10.1523/JNEUROSCI.2758-04.2004